RESEARCH PROJECTS

Project Title: Functional impact of epigenetic regulation in hepatocarcinoma: Development of combined nanovectorization of miRNAs/lncRNAs and drugs useful in experimental liver cancer model (PI19/01266)

Financial Entity: Instituto de Salud Carlos III

Lenght: 2020-21

Principal Investigator: Jordi Muntané

Working groups COST Action CA15203 MitoEAGLE: TG3.2 Liver and TG4.2 Cultured cells

Members of the COST Action CA15203 MitoEAGLE involved: Zuzana Červinková (Department of Physiology, Faculty of Medicine, Charles University, Hradec Kralove, Czech Republic)

Working groups COST Action CA15138 TRANSAUTOPHAGY: WG1: Basic Research on Autophagy Molecular Machinery; WG4: Biomedical Research (iv Cancer)

Members of the COST Action CA15138 TRANSAUTOPHAGY involved: Silvia Vega-Rubín-de-Celis (German Cancer Research Center, Heidelberg, DKFZ), Prasad Sulkshane (Technion-Israel Institute of Technology, Haifa. Israel) 

Granted: Submitted

 

Project Title: Determine if the dietary olive-based supplement a beneficial activity on different aspects related to metabolism, signaling, inflammation, as well as cell and tissue injury in the context of several in vitro and in vivo experimental models of metabolic syndrome (IFI18/00014)

Financial Entity: Instituto de Salud Carlos III

Lenght: 2019-22

Principal Investigator: Jordi Muntané

Fellowship: Elena Navarro-Villarán

Working groups COST Action CA15203 MitoEAGLE: TG3.2 Liver and TG4.2 Cultured cells

Members of the COST Action CA15203 MitoEAGLE involved: Zuzana Červinková (Department of Physiology, Faculty of Medicine, Charles University, Hradec Kralove, Czech Republic) and Pablo García-Roves (Department of Physiological Sciences, Faculty of Medicine and Health Sciences, University of Barcelona and Bellvitge Biomedical Research Institute (IDIBELL)

Granted: Approved

 

Project Title: Genetic, transcriptomic and proteomic markers related to the evolution of hepatocarcinoma, co-morbidities and response to treatments (PI16/00090)

Financial Entity: Instituto de Salud Carlos III

Lenght: 2017-19

Principal Investigator: Jordi Muntané

Granted: 152.460 Euros

 

Project Title: Secretion of extracellular vesicles and its relationship with the evolution of hepatocarcinoma, co-morbidities and response to treatments: Clinical and experimental study (PI-0198-2016)

Financial Entity: Consejería de Salud

Lenght: 2017-19

Principal Investigator: Raul González (1/1/2017-7/10/2018), María A. Rodríguez-Hernández (8/10/2018-31/12/2019)

Granted: 57.465,49 Euros

 

Project Title: Stratification of patients with hepatocarcinoma based on the detection and genetic and phenotypic analysis of CTCs: relationship with clinical evolution and response to treatment (PC-0522-2016-0043)

Financial Entity: Consejería de Salud

Lenght: 2017-19

Principal Investigator: José M. Álamo-Martínez

Granted: 16.100 Euros

 

Project Title: Search for new markers in cholangiocarcinoma (EHD15PI05, Acción Estratégica CIBERehd, Convocatoria 2015)

Financial Entity: Instituto de Salud Carlos III (2016-2017)

Lenght: 09/12/2015 – 09/12/2017

Principal Investigator; Rocío I. Rodríguez-Macías (Universidad de Salamanca-IBSAL)

Co-Investigator: Jesús M. Banales Asurmendi (Hospital Universitario de San Sebastián)

Co-Investigator: Bruno Sangro Gómez-Acebo (Clínica Universitaria de Navarra-CIMA)

Co-Investigator: Jordi Muntané (Hospital Universitario Virgen del Rocío de Sevilla)

Granted: 100.000 Euros (12.500 Euros each group/year)

 

Project Title: Regulation of cell death / proliferation and its relation to therapeutic efficacy in hepatocellular carcinoma: Role of genes in the p53 family and oxidative/nitrosative stress (PI13/00021)

Financial Entity: Instituto de Salud Carlos III

Lenght: 2014-16

Principal Investigator: Jordi Muntané Relat

Granted: 174.845 Euros

 

Project Title: Therapeutic efficacy of Sorafenib and immunosuppression in the treatment of hepatocellular carcinoma: Role of p53 family genes and oxidative and nitrosative stress. Multi-center multidisciplinary study (PI-00025-2013)

Financial Entity: Consejería de Igualdad, Salud y Políticas Sociales

Lenght: 2014-16

Principal Investigator: Javier Padillo

Granted: 51.669,82 Euros

 

Project Title: Antitumor activity of nitric oxide: Regulation by Sorafenib and / or inhibitors of the mTOR or Wnt / β-catenin pathway (CTS-6264)

Financial Entity: Consejería de Economía, Innovación, Ciencia y Empleo

Lenght: 2011-15

Principal Investigator: Dr. Jordi Muntané

Granted: 185.030 Euros

 

Project Title: Fatty liver inhibition of progression (FLIP). Call identifier: FP7-HEALTH-2009-single-stage

Proposal No: 241762

Financial Entity: 7TH European Framework Programme

Lenght: 2010-12

Principal Investigator: Vlad Ratziu

Co-Investigators: Servicio Andaluz de Salud (Jordi Muntané, Manuel Romero, Manuel de la Mata, Javier Salmerón, Emilio Gómez, Raúl J. Andrade, Agustín Ruiz, Juan D. Bautista),

Granted: 6 millones Euros (242.700 Euros para el nodo del Servicio Andaluz de Salud).

 

Project Title: Antitumor activity of nitric oxide: in vivo and in vitro studies (PI09/00185)

Financial Entity: Instituto de Salud Carlos III 

Lenght: 2010-12

Principal Investigator: Dr. Jordi Muntané

Granted: 114.345 Euros